Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- CDAK
- Price
- -
- Stock movement down
- -0.00 (-7.63%)
- Company name
- Codiak BioSciences Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology & Medical Research
- Market cap
- 445.64K
- Ent value
- 44.15M
- Price/Sales
- 0.02
- Price/Book
- 0.01
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -99.53%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
CDAK does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.02 |
| Price to Book | 0.01 |
| EV to Sales | 2.19 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 36.83M |
| EPS (TTM) | -1.56 |
| FCF per share (TTM) | -2.69 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 20.12M |
| Gross profit (TTM) | 16.86M |
| Operating income (TTM) | -53.30M |
| Net income (TTM) | -39.23M |
| EPS (TTM) | -1.56 |
| EPS (1y forward) | -1.39 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 83.79% |
| Operating margin (TTM) | -264.98% |
| Profit margin (TTM) | -195.01% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 51.76M |
| Net receivables | 0.00 |
| Total current assets | 61.23M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 134.40M |
| Accounts payable | 1.96M |
| Short/Current long term debt | 61.28M |
| Total current liabilities | 14.46M |
| Total liabilities | 95.47M |
| Shareholder's equity | 38.93M |
| Net tangible assets | 38.93M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -67.08M |
| Capital expenditures (TTM) | 694.00K |
| Free cash flow (TTM) | -67.77M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -100.77% |
| Return on Assets | -29.19% |
| Return on Invested Capital | -58.00% |
| Cash Return on Invested Capital | -100.21% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| CDAK | S&P500 | |
| Current price drop from All-time high | -99.96% | -10.40% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 3 May 2023 | 9 Mar 2009 |
| Avg drop from high | -68.20% | -11.07% |
| Avg time to new high | 67 days | 12 days |
| Max time to new high | 611 days | 1805 days |
COMPANY DETAILS
Marketcap
445.64K
Marketcap category
Small-cap
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. On March 27, 2023, Codiak BioSciences, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Employees
102
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner